ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants (Age 6 Months to <2 Years) With Functional Constipation Who Are Treated With Linaclotide

ClinicalTrials.gov ID: NCT05760313

Public ClinicalTrials.gov record NCT05760313. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 4:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Dose Finding Study Evaluating the Safety and Efficacy of Linaclotide in Pediatric Subjects 6 Months to Less Than 2 Years of Age With Functional Constipation (FC).

Study identification

NCT ID
NCT05760313
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AbbVie
Industry
Enrollment
19 participants

Conditions and interventions

Interventions

  • Linaclotide Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
6 Months to 23 Months
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 26, 2023
Primary completion
Jun 8, 2025
Completion
Jun 8, 2025
Last update posted
Jan 5, 2026

2023 – 2025

United States locations

U.S. sites
18
U.S. states
12
U.S. cities
17
Facility City State ZIP Site status
Velocity Clinical Research - Phoenix /ID# 263871 Phoenix Arizona 85006
HealthStar Research of Hot Springs PLLC /ID# 251553 Hot Springs Arkansas 71913
Advanced Research Center /ID# 248763 Anaheim California 92805
Kindred Medical Institute - Corona /ID# 251535 Corona California 92879-3104
Velocity Clinical Research Washington DC /ID# 263872 Washington D.C. District of Columbia 20016-4300
Prohealth Research Center /ID# 248696 Doral Florida 33166
South Miami Medical & Research Group Inc. /ID# 248765 Miami Florida 33155
Valencia Medical & Research Center /ID# 251533 Miami Florida 33165
Velocity Clinical Research Macon /ID# 263959 Macon Georgia 31210-6583
Velocity Clinical Research - Lafayette /ID# 263873 Lafayette Louisiana 70508
Frederick County Pediatrics /ID# 251555 New Market Maryland 21774-6154
Michigan Center of Medical Research /ID# 253536 Farmington Hills Michigan 48334
Velocity Clinical Research- Hastings Nebraska /ID# 260932 Hastings Nebraska 68901-2640
Coastal Pediatric Research - West Ashley B /ID# 248693 Charleston South Carolina 29414
Coastal Pediatric Research - Summerville /ID# 253534 Summerville South Carolina 29486
Houston Clinical Research Associates /ID# 261571 Houston Texas 77090-2633
Prime Clinical Research - Mansfield - East Broad Street /ID# 262947 Mansfield Texas 76063
ClinPoint Trials /ID# 251534 Waxahachie Texas 75165-1430

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05760313, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 5, 2026 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05760313 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →